TipRanks on MSN

Novo Nordisk’s SEMA-CardioDiab HUNGARY Study: A Potential Game-Changer for Diabetes Management

Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: The SEMA-CardioDiab HUNGARY study, officially titled ...

Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025

Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be ...